Clinical lumping and molecular splitting of LEOPARD and NF1/NF1-Noonan syndromes [1]

American Journal of Medical Genetics, Part A

Volumn 143, Issue 9, 2007, Pages 1009-1011

  Sarkozy, Anna ^a,b   Schirinzi, Annalisa ^a,b   Lepri, Francesca ^a,b   Bottillo, Irene ^a,b   De Luca, Alessandro ^a,b   Pizzuti, Antonio ^a,b   Tartaglia, Marco ^c   Digilio, Maria Cristina ^d   Dallapiccola, Bruno ^a,b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN;

GENE MUTATION; HUMAN; LEOPARD SYNDROME; LETTER; NEUROFIBROMATOSIS; NOONAN SYNDROME; PRIORITY JOURNAL;

DIAGNOSIS, DIFFERENTIAL; GENES, NEUROFIBROMATOSIS 1; HUMANS; LEOPARD SYNDROME; MOLECULAR DIAGNOSTIC TECHNIQUES; NOONAN SYNDROME;

EID: 34247866378     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31666     Document Type: Letter

References (30)

1. Allanson JE. 1987. Noonan syndrome. J Med Genet 24:9-13.
2. Baralle D, Mattocks C, Kalidas K, Elmslie F, WhittakerJ, Lees M, Ragge N, Patton MA, Winter RM, ffrench-Constant C. 2003. Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS). Am J Med Genet Part A 119A:1-8.
3. Carta C, Pantaleoni F, Bocchinfuso G, Stella L, Vasta I, Sarkozy A, Digilio C, Palleschi A, Pizzuti A, Grammatico P, Zampino G, Dallapiccola B, Gelb BD, Tartaglia M. 2006. Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype. Am J Hum Genet 79:129-135.
4. Cichowski K, Jacks T. 2001. NF1 tumor suppressor gene function: Narrowing the GAP. Cell 104:593-604.
5. Coppin BD, Temple IK. 1997. Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis). J Med Genet 34:582-586.
6. De Luca A, Buccino A, Gianni D, Mangino M, Giustini S1 Richetta A, Divona L, Calvieri S, Mingarelli R, Dallapiccola B. 2003. NF1 gene analysis based on DHPLC. Hum Mutat 21:171-172.
7. De Luca A, Bottillo I, Sarkozy A, Carta C, Neri C, Bellacchio E, Schirinzi A, Conti E, Zampino G, Battaglia A, Majore S, Rinaldi MM, Carella M, Marino B, Pizzuti A, Digilio MC, Tartaglia M, Dallapiccola B. 2005. NF1 gene mutations represent the major molecular event underlying neurofibromatosis- Noonan syndrome. Am J Hum Genet 77:1092-1101.
8. Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, Pizzuti A, Dallapiccola B. 2002. Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 71:389-394.
9. Digilio MC, Sarkozy A, de Zorzi A, Pacileo G, Limongelli G, Mingarelli R, Calabro R, Marino B, Dallapiccola B. 2006. LEOPARD syndrome: Clinical diagnosis in the first year of life. Am J Med Genet Part A 140A:740-746.
10. Friedman JM, Birch PH. 1997. Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70:138-143.
11. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D. 1997. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57.
12. Jamieson CR, van der Burgt I, Brady AF, van Reen M, Elsawi MM, Hol F, Jeffery S, Patton MA, Mariman E. 1994. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet 8:357-300.
13. Kalidas K, Shaw AC, Crosby AH, Newbury-Ecob R, Greenhalgh L, Temple IK, Law C, Patel A, Patton MA, Jeffery S. 2005. Genetic heterogeneity in LEOPARD syndrome: Two families with no mutations in PT PN11. J Hum Genet 50:21-25.
14. Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, De Paepe A. 2000. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15:541-555.
15. Neel BG, Gu H, Pao L. 2003. The 'Shping news': SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28:284-293.
16. Noonan JA. 1994. Noonan syndrome. An update and review for the primary pediatrician. Clin Pediatr (Phila) 33:548-555.
17. Opitz JM, Weaver DD. 1985. The neurofibromatosis-Noonan syndrome. Am J Med Genet 21:477-490.
18. Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, Li L, Yassin Y, Tamburino AM, Neel BG, Kucherlapati RS. 2007. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 39:70-74.
19. Sarkozy A, Conti E, Seripa D, Digilio MC, Grifone N, Tandoi C, Fazio VM, Di Ciommo V, Marino B, Pizzuti A, Dallapiccola B. 2003. Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet 40:704-708.
20. Sarkozy A, Conti E, Digilio MC, Marino B, Morini E. Pacileo G, Wilson M, Calabro R, Pizzuti A, Dallapiccola B. 2004. Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J Med Genet 41:e68.
21. Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G, van der Burgt I, Musante L, Kaischeuer V, Wehner LE, Nguyen H, West B, Zhang KY, Sistermans E, Rauch A, Niemeyer CM, Shannon K, Kratz CP. 2006. Germline KRAS mutations cause Noonan syndrome. Nat Genet 38:331-336.
22. Stumpf DA, Alksne JF, Annegers JF, Brown SS, Conneally PM, Housman D, Leppert MF, Miller JP, Moss ML, Pileggi AJ, Rapin I, Strohman RC, Swanson LW, Zimmerman A. 1988. Neurofibromatosis: Conference Statement. Arch Neurol 45:575-578.
23. Tartaglia M, Gelb BD. 2005. Noonan syndrome and related disorders: Genetics and pathogenesis. Annu Rev Genomics Hum Genet 6:45-68.
24. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD. 2001. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465-468.
25. Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD. 2002. PTPN11 mutations in Noonan syndrome: Molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70:1555-1563.
26. Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, Zampino G, Burgt I, Palleschi A, Petrucci TC, Sorcini M, Schoch C, Foa R, Emanuel PD, Gelb BD. 2006. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 78:279-290.
27. Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, Pandit B, Oishi K, Martinelli S, Schackwitz W, Ustaszewska A. Martin J, Bristow J, Carta C, Lepri F, Neri C, Vasta I, Gibson K, Curry CJ, Siguero JP, Digilio MC, Zampino G, Dallapiccola B, Bar-Sagi D, Gelb B. 2007. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 39:75-79.
28. Voron DA, Hatfield HH, Kalkhoff RK. 1970. Multiple lentigines syndrome. Case report and review of the literature. Am J Med 00:447-450.
29. Wu R, Legius E, Robberecht W, Dumoulin M, Cassiman JJ, Fryns JP. 1996. Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome. Hum Mutat 8: 51-50.
30. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, et al. 1990. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599-608.